Indeed, the correlation between ZRANB3 and TP53 is observed across tumours overall, but it is modulated by TP53 mutations and high proliferation rates, ultimately supporting the hypothesis of a functional ZRANB3/p53 axis in cancer. Here, ZRANB3 is linked to neoplasm.